Description
Cefixime has emerged as a valuable oral treatment option for managing multi-drug-resistant (MDR) enteric fever in children. Clinical findings from a study conducted among 85 patients with enteric fever indicate that cefixime provides effective therapy with good tolerance, making it a practical alternative to parenteral agents.
Its oral administration not only improves compliance and comfort for pediatric patients but also reduces the need for hospitalization and the costs associated with intravenous therapy.
As antimicrobial resistance continues to rise, cefixime represents an important tool in expanding treatment options for MDR enteric fever.